The AHA in comments today to the Centers for Medicare & Medicaid Services on its interim final rule for its COVID-19 vaccine mandate for hospitals and other participants in the Medicare and Medicaid program urged the agency to be flexible as it begins enforcement. Such flexibility and discretion in CMS’ enforcement, AHA said, will help mitigate uncertainty as court challenges to the mandate persist, while enabling hospitals and health systems to navigate workforce challenges without disrupting patient care. AHA also asked CMS to provide clarification for the agency’s complex, broad-sweeping interpretive guidance, including developing a means for hospitals to quickly get answers to their questions on compliance with the interim final rule.

Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…